FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Denton David M 		2. Issuer Name and Ticker or Trading Symbol

CVS HEALTH Corp [ CVS ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
EVP and CFO
(Last)          (First)          (Middle)

ONE CVS DRIVE 		3. Date of Earliest Transaction (MM/DD/YYYY)

9/11/2017
(Street)

WOONSOCKET, RI 02895-
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   9/11/2017     S (1)    23855   D $79.61   (2) 141096.399   D    
Common Stock   9/11/2017     S (1)    105040   D $79.68   (3) 36056.399   D    
Common Stock   9/11/2017     M    108183   A $54.53   144239.399   D    
Common Stock   9/11/2017     S (1)    108183   D $79.62   (4) 36056.399   D    
Common Stock (restricted)                  152877   D    
ESOP Common Stock                  1710.1708   I   By ESOP  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option   $54.53   9/11/2017     M         108183    4/1/2014   (5) 4/1/2020   Common Stock   108183   $0   0   D    
Stock Option   $74.29                    4/1/2015   (6) 4/1/2021   Common Stock   62943     62943   D    
Stock Option   $102.26                    4/1/2016   (7) 4/1/2022   Common Stock   59922     59922   D    
Stock Option   $104.82                    4/1/2017   (8) 4/1/2023   Common Stock   71696     71696   D    
Stock Option   $78.05                    4/3/2018   (9) 4/3/2024   Common Stock   100179     100179   D    

Explanation of Responses:
(1)  All sales were effected pursuant to a Rule 10b5-1 plan.
(2)  Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $79.33 and $80.00 per share.
(3)  Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $79.35 and $80.00 per share.
(4)  Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $79.33 and $80.00 per share.
(5)  Option became exercisable in four equal annual installments, commencing 4/1/2014.
(6)  Option became exercisable in four equal annual installments, commencing 4/1/2015.
(7)  Option became exercisable in four equal annual installments, commencing 4/1/2016.
(8)  Option became exercisable in four equal annual installments, commencing 4/1/2017.
(9)  Option becomes exercisable in four equal annual installments, commencing 4/3/2018.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Denton David M
ONE CVS DRIVE
WOONSOCKET, RI 02895-

EVP and CFO

Signatures
/c/ David M. Denton 9/12/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
CVS Health (NYSE:CVS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more CVS Health Charts.
CVS Health (NYSE:CVS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more CVS Health Charts.